Jennison Associates’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.6M Sell
453,216
-151,972
-25% -$9.89M 0.03% 247
2026
Q1
$28.8M Sell
605,188
-13,745
-2% -$616K 0.02% 289
2025
Q4
$19.6M Sell
618,933
-15,667
-2% -$489K 0.01% 342
2025
Q3
$17.9M Buy
634,600
+16,350
+3% +$495K 0.01% 336
2025
Q2
$22.7M Buy
618,250
+41,469
+7% +$1.43M 0.01% 319
2025
Q1
$22.6M Sell
576,781
-103,997
-15% -$4.68M 0.02% 324
2024
Q4
$31.6M Buy
680,778
+302,884
+80% +$13.7M 0.02% 289
2024
Q3
$17.1M Buy
377,894
+86,399
+30% +$4.11M 0.01% 358
2024
Q2
$14.4M Buy
291,495
+141,473
+94% +$5.77M 0.01% 358
2024
Q1
$5.15M Buy
150,022
+125,946
+523% +$4.55M ﹤0.01% 434
2023
Q4
$887K Sell
24,076
-8,370
-26% -$194K ﹤0.01% 503
2023
Q3
$657K Sell
32,446
-15,158
-32% -$333K ﹤0.01% 516
2023
Q2
$974K Buy
+47,604
New +$713K ﹤0.01% 485
2021
Q3
Sell
-7,936
Closed -$1.06M 730
2021
Q2
$1.06M Sell
7,936
-94,006
-92% -$10.9M ﹤0.01% 622
2021
Q1
$12.6M Sell
101,942
-189,148
-65% -$28.7M 0.01% 401
2020
Q4
$41.1M Buy
291,090
+81,677
+39% +$9.06M 0.03% 242
2020
Q3
$15.9M Buy
+209,413
New +$13M 0.01% 331

Other funds holding TWST

Jennison Associates's TWST Position: Q2 2026 in Review

Jennison Associates reduced its Twist Bioscience (TWST) stake by 25% in Q2 2026, selling an estimated $9.89M and leaving 453,216 shares worth $46.6M. The position accounts for 0.03% of the portfolio, ranked #247.

Jennison Associates first reported a position in TWST in Q3 2020 and has held it in 17 quarters since. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Jennison Associates held 453,216 shares of Twist Bioscience worth $46.6M as of Q2 2026.
  • Jennison Associates sold 151,972 Twist Bioscience shares in Q2 2026, an estimated $9.89M.
  • Twist Bioscience made up 0.03% of Jennison Associates's portfolio in Q2 2026, its #247 holding.
  • Jennison Associates first reported a position in Twist Bioscience in Q3 2020 and has held it in 17 quarters since.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.